- Home
- SVRA vs IQ Comparison
SVRA vs IQ Comparison
Compare SVRA & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | IQ |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 917.9M |
| IPO Year | 2009 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SVRA | IQ |
|---|---|---|
| Price | $4.52 | $0.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 19 |
| Target Price | ★ $11.06 | $1.34 |
| AVG Volume (30 Days) | 2.6M | ★ 4.7M |
| Earning Date | 11-11-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4,406.08 | $2.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.86 | $0.86 |
| 52 Week High | $7.01 | $2.36 |
Technical Indicators
Market Signals| Indicator | SVRA | IQ |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 34.50 |
| Support Level | N/A | $0.86 |
| Resistance Level | $5.53 | $1.18 |
| Average True Range (ATR) | 0.26 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 7.38 | 5.15 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.